Juan Jesús Cruz Hernández-rekin lankidetzan egindako argitalpenak (1)

2018

  1. First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii183